We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDC
401
DELISTED
Rowan Companies Plc
RDC
| $2.66M | 0.01% |
75,270
+8,896
| +13% | +$318K |
|
402
iShares Russell 2000 ETF
IWM
$80.9B
| $2.64M | 0.01% |
22,895
-1,025
| -4% | -$113K |
|
403
Arthur J. Gallagher & Co
AJG
$63.7B
| $2.63M | 0.01% |
56,148
+1,683
| +3% | +$78.2K |
|
404
Essential Utilities
WTRG
$11.2B
| $2.6M | 0.01% |
110,273
-766
| -0.7% | -$18.7K |
|
|
CXO
405
DELISTED
CONCHO RESOURCES INC.
CXO
| $2.58M | 0.01% |
23,914
+14,875
| +165% | +$1.61M |
|
406
Phillips 66
PSX
$82.9B
| $2.58M | 0.01% |
33,457
-684
| -2% | -$45.6K |
|
407
iShares MSCI EAFE Growth ETF
EFG
$16.3B
| $2.57M | 0.01% |
35,943
+307
| +0.9% | +$21.3K |
|
|
ATHN
408
DELISTED
Athenahealth, Inc.
ATHN
| $2.53M | 0.01% |
18,807
+1,406
| +8% | +$181K |
|
409
Markel Group
MKL
$25B
| $2.52M | 0.01% |
4,351
+2,385
| +121% | +$1.29M |
|
|
WLL
410
DELISTED
Whiting Petroleum Corporation
WLL
| $2.52M | 0.01% |
136
+3
| +2% | +$56.8K |
|
411
Labcorp
LH
$24.3B
| $2.52M | 0.01% |
32,062
-2,878
| -8% | -$245K |
|
412
Healthpeak Properties
DOC
$15.4B
| $2.52M | 0.01% |
76,028
+1,010
| +1% | +$36K |
|
413
Vanguard High Dividend Yield ETF
VYM
$81.1B
| $2.51M | 0.01% |
40,345
| – | – |
|
414
Vanguard Mid-Cap ETF
VO
$106B
| $2.5M | 0.01% |
90,776
-6,888
| -7% | -$183K |
|
|
RHT
415
DELISTED
Red Hat Inc
RHT
| $2.43M | 0.01% |
43,410
+23,650
| +120% | +$1.1M |
|
416
iShares MSCI EAFE Value ETF
EFV
$27.6B
| $2.42M | 0.01% |
42,332
| – | – |
|
|
MON
417
DELISTED
Monsanto Co
MON
| $2.39M | 0.01% |
20,526
-6,520
| -24% | -$712K |
|
418
Golub Capital BDC
GBDC
$3.33B
| $2.38M | 0.01% |
127,367
-3,185
| -2% | -$55.4K |
|
419
American International
AIG
$41.9B
| $2.32M | 0.01% |
45,517
+1,738
| +4% | +$86.6K |
|
420
NextEra Energy
NEE
$187B
| $2.32M | 0.01% |
108,588
-3,700
| -3% | -$78K |
|
421
H&R Block
HRB
$5.18B
| $2.32M | 0.01% |
79,850
| – | – |
|
|
PCP
422
DELISTED
PRECISION CASTPARTS CORP
PCP
| $2.32M | 0.01% |
8,602
-341
| -4% | -$85.8K |
|
423
iShares Russell 1000 Growth ETF
IWF
$122B
| $2.25M | 0.01% |
104,588
+6,916
| +7% | +$142K |
|
424
Helmerich & Payne
HP
$3.53B
| $2.25M | 0.01% |
26,700
-2,560
| -9% | -$199K |
|
425
Moody's
MCO
$81.7B
| $2.24M | 0.01% |
28,569
+15,786
| +123% | +$1.16M |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.